Who owns YS BIOPHARMA CO LTD?
- Ticker: YSBPW
- CUSIP Number: g9845f117
Tip: Access positions for across all investors
Analyze quarterly positions in Ys Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ys Biopharma stock
Who bought or sold YS BIOPHARMA CO LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Millennium Management | 1.1M | $57k | 0% | Mar 2024 |
|
| LMR Partners | 1.1M | $75k | 0% | Mar 2024 |
|
| Valliance Asset Management | 750k | $54k | 0% | Mar 2024 |
|
| BFAM Partners | 550k | $28M | 0% | Mar 2024 |
|
| Jane Street | 498k | $36k | 0% | Mar 2024 |
|
| Finepoint Capital | 490k | $25k | 0% | Mar 2024 |
|
| Highbridge Capital Management | 439k | $35M | -18% | Mar 2024 |
|
| Cowen And Company | 236k | $17k | 18% | Mar 2024 |
|
| Bracebridge Capital | 232k | $17k | 0% | Mar 2024 |
|
| Calamos Advisors | 146k | $7.4k | 0% | Mar 2024 |
|
| Q Global Advisors | 131k | $9.0k | 0% | Mar 2024 |
|
| Athos Capital | 129k | $93k | 0% | Mar 2024 |
|
| Whitebox Advisors | 125k | $9.0k | 0% | Mar 2024 |
|
| D. E. Shaw & Co | 100k | $5.1k | 0% | Mar 2024 |
|
| Walleye Trading Advisors | 100k | $7.2k | 0% | Mar 2024 |
|
| Saba Capital Management | 97k | $7.0k | 0% | Mar 2024 |
|
| Cantor Fitzgerald, L. P. | 77k | $6.0k | 0% | Mar 2024 |
|
| Shaolin Capital Management | 76k | $5.5k | -24% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 75k | $5.3k | 0% | Mar 2024 |
|
| Exos TFP Holdings | 50k | $1.9k | -49% | Dec 2023 |
|
| Exos Asset Management | 50k | $3.6k | 100% | Mar 2024 |
|
| Clear Street | 47k | $3.0k | 0% | Mar 2024 |
|
| Elequin Capital | 38k | $1.4k | 0% | Dec 2023 |
|
| Meteora Capital | 25k | $1.8k | 0% | Mar 2024 |
|
| Citadel Advisors | 22k | $1.1k | 100% | Mar 2024 |
|
| SkyView Investment Advisors | 12k | $999.999000 | 0% | Mar 2024 |
|
| Ancora Advisors | 5.1k | $362.085000 | 0% | Mar 2024 |
|
| HGC Investment Management | 5.0k | $358.000000 | 0% | Mar 2024 |
|
| Tower Research Capital | 126.00 | $8.996400 | 0% | Mar 2024 |
|
| UBS Group | 68.00 | $4.998000 | 100% | Mar 2024 |
|
Who sold out of Ys Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Snow Lake Management | Sep 2023 | 500k | $21k |
| BosValen Asset Management | Dec 2023 | 39k | $1.5k |
| Wolverine Asset Management | Dec 2023 | 1.2k | $45.000000 |